Cookies are used to help provide a better web service to patients and others.
Uses include: remembering products you add to our cart, understanding what people need and ensuring our website works properly.
Our service contains information about acquiring treatments that have been approved in another country. This includes professional information such as approval details, product information and pricing. By continuing, you are declaring that you are requesting any such information.
If you suffer from migraine and you feel as if it’s impacting your relationships, work and personal life, you’re not alone. Migraine is the third most common disease worldwide, affecting around 1 in 7 people*. If you feel like you’ve used all treatment options and nothing has worked, you’re not alone either. Many migraine patients feel like painkillers and other migraine medicines do not work for them, or they can’t take them long-term. But now there’s a new hope.
*According to The Migraine Trust
Please note this page contains information about overseas approved prescription medicines. This includes transparent information such as clinical trials published, how the product works and pricing. If you scroll down, you declare yourself as requesting this information.
The newly approved migraine injection
Erenumab (Aimovig) is a newly approved migraine injection that could offer new hope for people who suffer from migraine. According to the Food and Drug Administration (FDA), erenumab (Aimovig) is, globally, the first and only approved CGRP receptor blocker and the first in a new class of preventative migraine medicines1.
What is erenumab (Aimovig)?
Erenumab (Aimovig) is an injection for migraine, which is taken once per month. Clinical studies published by the FDA show that it may offer relief for people with chronic and episodic migraine, by blocking specific molecules that are thought to play a role in migraine.2 There are multiple medicines in this field currently being studied (fremanezumab, for example), which could mean others are approved in the future.
Read here for more information about treatment expenses and availability.
How effective is erenumab (Aimovig) according to the studies?
Aimovig 70 mg
Aimovig 140 mg
*. Aimovig™ (erenumab-aooe) prescribing information, Amgen. ** Goadsby PJ, Reuter U, Hallström Y, et al. A controlled trial of erenumab for episodic migraine. N Engl J Med. 2017;377(22):2123-2132. *** Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial Tepper, Stewart et al. The Lancet Neurology , Volume 16 , Issue 6 , 425 - 434
How to use the new migraine injection (erenumab)*
*This information is not intended to be a guide for taking erenumab (Aimovig). Please consult the full prescribing information and administration instructions before using erenumab (Aimovig).
How do these new blockers like erenumab (Aimovig) work?
How can I get erenumab (Aimovig)?
It may be the case that erenumab is not yet approved or available in your country, which may mean you will experience delays in accessing this medicine. We’re here to help.
With a prescription from your treating doctor TheSocialMedwork can support you to obtain erenumab (Aimovig) from outside your country. Our team of pharmacists and regulatory experts delivers elsewhere approved medicines around the world every day. They are ready to assist with sourcing and delivery, and will guide you through every step of the process.
Migraine is a challenging and under-recognised disorder. If you’d like to ask questions about erenumab (Aimovig), how to get it, or about any other migraine treatments, our team of qualified pharmacists and experts are ready to offer support and assist with queries. Our team speaks 17 different languages and is ready to help.
TheSocialMedwork makes the latest approved medicines available to patients, hospitals and doctors around the world, in a legal and compliant way. We source the best possible prices for innovative medicines and ensure safe, efficient and legally compliant delivery. We have successful deliveries in over 60 countries worldwide, with 100% quality service reviews by doctors and patients.